Safety of parenteral third-generation cephalosporins

The American Journal of Medicine

Volumn 88, Issue 4 SUPPL. 1, 1990, Pages

  Fekety, F Robert ^a  

^a UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN DERIVATIVE;

ADVERSE DRUG REACTION; BACTERIAL INFECTION; BLEEDING; CONFERENCE PAPER; DRUG SAFETY; GASTROINTESTINAL DISEASE; HUMAN; HYPOPROTHROMBINEMIA; PRIORITY JOURNAL; THEORETICAL STUDY; THROMBOCYTOPENIA; CHEMISTRY; REVIEW; SAFETY;

CEPHALOSPORINS; CHEMISTRY; HUMAN; SAFETY;

EID: 0025703606     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9343(90)90326-9     Document Type: Article

References (40)

1. Adverse effects of third-generation cephalosporins
2. Comparative toxicities of third-generation cephalosporins
3. Hypoprothrombinemia caused by cephalosporins
4. Hemorrhagic complications of cephalosporin therapy
5. Impaired hemostasis caused by beta-lactam antibiotics
6. Cephalosporin induced hypoprothrombinemia: possible role for thiol-methylation of 1-methyltetrazole-5-thiol and 2-methyl-1,3,4-thiadiazole-5-thiol
7. Effects of moxalactam on blood coagulation and platelet function
8. New beta-lactam antibiotics and hemorrhagic diathesis-comparison of moxalactam and cefotaxime
9. Enhanced bleeding with cefoxitin or moxalactam: statistical analysis within a defined population of 1493 patients
10. Alteration of hemostasis associated with cefoperazone treatment
11. Hypoprothrobinaemic bleeding associated with ceftriaxone
12. Vitamin K-dependent proteins
13. Production of menaquinones by intestinal anaerobes
14. Coagulation defects
15. The effects of latamoxef, cefotaxime, and cefoperazone on platelet function and coagulation in normal volunteers
16. Carbenicillin and penicillin G inhibit platelet function in vitro by impairing the interaction of agonists with the platelet surface
17. Prolonged bleeding times and bleeding diathesis associated with moxalactam administration
18. Moxalactam
19. Cross-reactivity between penicillins and cephalosporins: clinical and immunologic studies
20. Immunologic cross-reactivity between penicillins and cephalosporins: a review
21. Cefotaxime and cephalosporins: adverse reactions in perspective
22. Chemotherapeutic agents: aspects of their activity on natural mechanisms of defense against infections
23. Ceftriaxone: renal and biliary excretion and effect on the colonic microflora
24. Influence of third-generation cephalosporins on aerobic intestinal flora
25. The influence of third-generation cephalosporins on the aerobic intestinal flora
26. Gastrointestinal side effects
27. Reversible cetriaxone-associated biliary pseudolithiasis in children
28. Ceftriaxone-associated cholelithiasis
29. Displacement effect of ceftriaxone and bilirubin bound to human serum albumin
30. In vitro displacement of bilirubin by antibiotics and 2-hydroxybenzoylglycine in newborns
31. The activity of cefotaxime and desacetyl cefotaxime alone and in combination against anaerobes and staphylococci
32. Superinfections
33. Ceftazidime therapy of serious bacterial infections
34. Gram-positive superinfections following beta-lactam chemotherapy: the significance of the Enterococcus
35. Ceftazidime and renal function
36. Renal tolerance of ceftazidime in animals
37. Aminoglycoside toxicity—a review of clinical studies published between 1975 and 1982
38. Ethanol moxalactam interactions in vivo
39. Clinical adverse effects during ceftriaxone therapy